A PD-L1xCD3 bispecific nanobody as a novel T-cell engager in treating PD-L1 overexpression melanoma
Boping Li, Boping Li, Shuang Wang, Baihui Shan, Baizhi Li, Baizhi Li, Fuqiu Li
Topics & Concepts
BlockadeCD3MelanomaCancer researchImmune checkpointT cellAntibodyCytotoxic T cellPD-L1ChemistryImmune systemMedicineMolecular biologyImmunotherapyCD8ImmunologyBiologyIn vitroReceptorBiochemistryCAR-T cell therapy researchMonoclonal and Polyclonal Antibodies ResearchCancer Immunotherapy and Biomarkers